Nantahala Capital Management - aVenture Asset Manager Research
Nantahala Capital Management
Operating Status: Operating
Nantahala Capital Management: A diversified strategy hedge fund.
Location
New Canaan, CT, US
Founded
2004
Nantahala Capital Management is a hedge fund with a diversified strategy, focusing primarily on post-IPO equity investments. The firm typically engages in later-stage funding rounds, supporting companies that have already gone public. Nantahala's investment approach allows it to provide substantial financial backing to its portfolio companies, often participating in significant funding rounds.
The firm's portfolio includes notable companies such as Abeona Therapeutics, DarioHealth, and Lyra Therapeutics, with substantial total raises of $35 million, $98.6 million, and $150.5 million, respectively. Nantahala Capital Management distinguishes itself by leveraging its diversified investment strategies to add value beyond capital, offering strategic guidance and support to its portfolio companies. Key decision-makers at the firm bring extensive experience and a strong track record in the investment industry, contributing to the firm's reputation and success.
Nantahala Capital Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies11
Follow-on Investments2
Current Portfolio Count11
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
